Research Signal – Source date 2022-01-30
A review of gut-focused supplement trials in young people found a striking split: about half of the studies assessing cognition reported a positive result, while evidence for easing anxiety and stress was limited and inconsistent. That difference invites a question: do these supplements affect thinking more than emotion, or were the studies too different to make a fair comparison?
The review cannot settle that comparison. Its 19 cognition studies and 17 anxiety or stress studies were not matched experiments, and some studies assessed both kinds of outcome. Participants’ ages, supplements, treatment periods and measures varied. The findings are a useful account of what researchers had observed by the review’s search in October 2020, but they do not establish a dependable benefit for young people generally or support choosing a particular product.
What counts as a psychobiotic?
The review uses “psychobiotic” for gut-focused interventions intended to influence brain-related outcomes. Probiotics are live microorganisms; prebiotics are substances intended to support beneficial gut microbes. These are broad categories, not interchangeable ingredients: studies used different organisms, fibers and other preparations.
Some trials using omega-3 fats, including DHA and EPA, were also grouped with prebiotics. The authors’ rationale was that these fats may have prebiotic effects on the gut microbiome. They acknowledge that not all supplements included under that label are conventionally recognized as prebiotics. That category choice matters when comparing results: a finding from one preparation does not automatically describe every supplement called a psychobiotic.
Similar outcomes came from different studies
The authors searched six databases for controlled human trials, with searches conducted from 18 to 27 October 2020. Eligible trials compared an active prebiotic or probiotic treatment with a comparator and measured anxiety, stress or cognition in populations with a mean age between 6 and 25. The review included both healthy and clinical populations. Its publication on 30 January 2022 does not extend the search cutoff; later studies are outside the evidence considered here.
The authors synthesized the findings qualitatively rather than calculating one pooled effect. That choice reflects a practical comparison problem: studies examined different populations, doses, treatment lengths and measures. “Cognition,” for example, covered outcomes such as attention, memory, inhibition and executive function. A result on one task or rating scale cannot be combined straightforwardly with a different kind of cognitive measure to produce a single estimate of benefit.
The groups also tended to differ in ways that traveled together. Prebiotic studies more often focused on cognition, involved participants younger than 14 and lasted longer. Probiotic studies more often involved young adults, were shorter and focused on anxiety or stress. The review reports that anxiety effects seemed to appear in longer interventions than stress effects, but differences in the trials make that pattern difficult to isolate. Age, ingredient, duration and outcome were not held constant while researchers switched only from measuring thinking to measuring anxiety.
That matters for the apparent split. About half of the cognition studies reported success, which the authors describe as encouraging. For anxiety and stress, they found limited evidence of efficacy. But the evidence does not show that the same supplement works better for cognition than for anxiety when tested under equivalent conditions. The outcome groups provide an imperfect comparison, not a head-to-head ranking.
The review also assessed risk of bias, including randomization, blinding, missing data and selective reporting. Among the 17 anxiety or stress records, one was assessed as having low risk of bias and six as having high risk. Reported concerns included unclear randomization procedures, lack of detailed protocols, and problems accounting for dropouts. These design issues add to the difficulty of reading a collection of varied results as a settled pattern.
A gut effect might not cross every domain
Some trials measured both cognitive and emotional outcomes, offering a small test of whether an intervention might improve overall functioning rather than one specific result. One four-week prebiotic study reported improvement in both cognition and emotional measures. In other studies, a change appeared in cognition or in anxiety or stress, or there was no improvement. The pattern leaves open whether effects depend on the intervention, the outcome or the people studied.
Probiotic results illustrate that specificity. In the review’s account, one study reported improved sustained attention in young football players after 56 days of a probiotic. Another found improved working memory during a short-term stress challenge after 28 days of a multispecies probiotic. Other probiotic studies did not find significant treatment effects. These examples concern particular participants, preparations and tests; they do not establish that probiotics as a category improve attention or memory.
A change in an attention task or anxiety score also cannot, by itself, show that gut microbes caused the change. The review describes psychobiotic effects as involving a proposed gut–brain connection, but behavioral outcomes alone do not establish the steps in that connection. To examine it, the authors recommend measuring gut microbiome composition before and after treatment, alongside factors such as food intake, sleep and physical activity that can relate to both the microbiome and behavior. Those measurements could help researchers ask whether a behavioral change tracks a microbiome change, and whether other influences offer a better explanation.
What this could change
A family and clinician considering a young person’s anxiety or attention could eventually have evidence specific enough to answer a practical question: has this particular preparation shown a dependable effect for this age group and outcome? That would make it easier to distinguish a supported option from a broad promise about gut health. The supplements already exist; what is missing is dependable, outcome-specific guidance that can tell people whether one preparation is supported for a particular purpose.
Getting there depends on comparable trials that test a specified intervention in a defined population, use consistent validated outcomes and measure the gut alongside behavior. One nearer milestone would be an independent placebo-controlled replication using a specified preparation and comparable outcome measures, with microbiota assessed before and after treatment. If such replications produced consistent results, researchers and clinicians could better judge whether a finding applies beyond one study. Until then, this review’s contribution is to show both the promising cognitive results and the study differences that keep them from answering the comparison cleanly.
Key Sources
- Primary source: A Systematic Review of Psychobiotic Interventions in Children and Adolescents to Enhance Cognitive Functioning and Emotional Behavior.
DOI or Journal Page · Review or Meta-Analysis · 2022-01-30
Keep exploring